165 related articles for article (PubMed ID: 31416738)
41. Aromatase inhibitory activity of 1,4-naphthoquinone derivatives and QSAR study.
Prachayasittikul V; Pingaew R; Worachartcheewan A; Sitthimonchai S; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
EXCLI J; 2017; 16():714-726. PubMed ID: 28827987
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.
Acar Çevik U; Kaya Çavuşoğlu B; Sağlık BN; Osmaniye D; Levent S; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Apr; 25(7):. PubMed ID: 32252458
[TBL] [Abstract][Full Text] [Related]
43. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids.
Takahashi M; Yamashita K; Numazawa M
Steroids; 2010 Apr; 75(4-5):330-7. PubMed ID: 20096721
[TBL] [Abstract][Full Text] [Related]
44. Integrated in silico-in vitro strategy for screening of some traditional Egyptian plants for human aromatase inhibitors.
Dawood HM; Ibrahim RS; Shawky E; Hammoda HM; Metwally AM
J Ethnopharmacol; 2018 Oct; 224():359-372. PubMed ID: 29909120
[TBL] [Abstract][Full Text] [Related]
45. In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations.
Wang M; Wang Y; Kong D; Jiang H; Wang J; Cheng M
Comput Biol Chem; 2018 Dec; 77():214-225. PubMed ID: 30359866
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Oda K
Bioorg Med Chem Lett; 2017 Jun; 27(12):2645-2649. PubMed ID: 28512028
[TBL] [Abstract][Full Text] [Related]
47. Aryl Bis-Sulfonamide Inhibitors of IspF from Arabidopsis thaliana and Plasmodium falciparum.
Thelemann J; Illarionov B; Barylyuk K; Geist J; Kirchmair J; Schneider P; Anthore L; Root K; Trapp N; Bacher A; Witschel M; Zenobi R; Fischer M; Schneider G; Diederich F
ChemMedChem; 2015 Dec; 10(12):2090-8. PubMed ID: 26435072
[TBL] [Abstract][Full Text] [Related]
48. Pharmacophore mapping of flavone derivatives for aromatase inhibition.
Nagar S; Islam MA; Das S; Mukherjee A; Saha A
Mol Divers; 2008 Feb; 12(1):65-76. PubMed ID: 18506592
[TBL] [Abstract][Full Text] [Related]
49. Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
Adhikari N; Baidya SK; Jha T
Eur J Med Chem; 2020 Dec; 208():112845. PubMed ID: 33017749
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study.
Taha M; Irshad M; Imran S; Chigurupati S; Selvaraj M; Rahim F; Ismail NH; Nawaz F; Khan KM
Eur J Med Chem; 2017 Dec; 141():530-537. PubMed ID: 29102178
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.
Leonetti F; Favia A; Rao A; Aliano R; Paluszcak A; Hartmann RW; Carotti A
J Med Chem; 2004 Dec; 47(27):6792-803. PubMed ID: 15615528
[TBL] [Abstract][Full Text] [Related]
52. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
53. Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
Bonfield K; Amato E; Bankemper T; Agard H; Steller J; Keeler JM; Roy D; McCallum A; Paula S; Ma L
Bioorg Med Chem; 2012 Apr; 20(8):2603-13. PubMed ID: 22444875
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Sun B; Hoshino J; Jermihov K; Marler L; Pezzuto JM; Mesecar AD; Cushman M
Bioorg Med Chem; 2010 Jul; 18(14):5352-66. PubMed ID: 20558073
[TBL] [Abstract][Full Text] [Related]
55. Pharmacophore based 3D-QSAR study of biphenyl derivatives as nonsteroidal aromatase inhibitors in JEG-3 cell lines.
Bheemanapalli LN; Balakumar C; Kaki VR; Kaur R; Akkinepally RR
Med Chem; 2013 Nov; 9(7):974-84. PubMed ID: 22974288
[TBL] [Abstract][Full Text] [Related]
56. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
[TBL] [Abstract][Full Text] [Related]
58. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
[TBL] [Abstract][Full Text] [Related]
59. Novel sulfonanilide analogs decrease aromatase activity in breast cancer cells: synthesis, biological evaluation, and ligand-based pharmacophore identification.
Su B; Tian R; Darby MV; Brueggemeier RW
J Med Chem; 2008 Mar; 51(5):1126-35. PubMed ID: 18271519
[TBL] [Abstract][Full Text] [Related]
60. Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studies.
Abd El-Karim SS; Anwar MM; Syam YM; Nael MA; Ali HF; Motaleb MA
Bioorg Chem; 2018 Dec; 81():481-493. PubMed ID: 30243239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]